lithium has been researched along with Cognitive Decline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 11 (55.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Li, Y; Luo, X; Ren, S; Wang, L; Wu, G; Wu, J; Wu, Q | 1 |
| Li, S; Luo, X; Ma, M; Wu, Y; Xiang, T; Zeng, C | 1 |
| Honyashiki, M; Inoue, T; Terao, I | 1 |
| Bezerra, GAM; Corradi, MM; Damiano, RF; Di Santi, T; Forlenza, OV; Loureiro, JC; Pais, MV; Pereira, RF; Radanovic, M; Talib, LL | 1 |
| Cai, Z; Chen, G; Chen, J; Li, Q; Li, R; Ma, X; Song, X; Tian, H; Xu, Y; Yang, L; Zhang, Q; Zhou, C; Zhuo, C | 1 |
| Bachu, A; Madangarli, N; Patel, RS; Youssef, NA | 1 |
| Chen, C; Chen, G; Cheng, L; Fang, T; Ping, J; Sun, Y; Tian, H; Wang, L; Zhu, J; Zhuo, C | 1 |
| Dyomina, AV; Smolensky, IV; Zaitsev, AV | 1 |
| Crocco, E; Deliyannides, DA; Devanand, DP; Forester, BP; Graff, JA; Husain, MM; Lee, S; Niño, I; Vahia, IV | 1 |
| Bang, J; Jeon, WK; Kim, MS | 1 |
| Ahmad, M; Taweel, GMA | 1 |
| Blomgren, K; Culmsee, C; Dolga, AM; Kogner, P; Li, T; Wickström, M; Xie, C; Xu, Y; Zhang, Y; Zhou, K; Zhu, C | 1 |
| Clotet, B; Díez-Quevedo, C; Ferrer, MJ; Fumaz, CR; Garolera, M; Miranda, C; Moltó, J; Muñoz-Moreno, JA; Pérez-Álvarez, N; Prats, A | 1 |
| Cai, Q; Gan, J; Li, S; Luo, R; Mu, D; Qu, Y; Wan, C | 1 |
| Fan, Z; Feng, X; Yin, S; Zhu, X | 1 |
| Forlenza, OV; Gattaz, WF; Radanovic, M; Talib, LL | 1 |
| Aprahamian, I; Diniz, BS; dos Santos, B; Forlenza, OV; Gattaz, WF; Radanovic, M; Santos, FS; Talib, L | 1 |
| Lozano, R | 1 |
| Aprahamian, I; Forlenza, OV | 1 |
| Kalemenev, SV; Kim, KK; Lavrent'eva, VV; Lukomskaya, NY; Magazanik, LG; Sizov, VV; Zaitsev, AV; Zubareva, OE | 1 |
1 review(s) available for lithium and Cognitive Decline
| Article | Year |
|---|---|
Comparative efficacy of lithium and aducanumab for cognitive decline in patients with mild cognitive impairment or Alzheimer's disease: A systematic review and network meta-analysis.
Topics: Acetylcholinesterase; Alzheimer Disease; Antibodies, Monoclonal, Humanized; Cholinesterase Inhibitors; Cognitive Dysfunction; Humans; Lithium; Network Meta-Analysis; United States | 2022 |
5 trial(s) available for lithium and Cognitive Decline
| Article | Year |
|---|---|
Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Humans; Lithium | 2023 |
Effects of lithium on serum Brain-Derived Neurotrophic Factor in Alzheimer's patients with agitation.
Topics: Alzheimer Disease; Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Humans; Lithium | 2023 |
Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
Topics: Administration, Cutaneous; Adult; Anti-Retroviral Agents; Cognitive Dysfunction; Executive Function; Female; HIV Infections; Humans; Lithium; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Pilot Projects; Rivastigmine; Treatment Outcome | 2017 |
Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Disease Progression; Humans; Lithium; Neuropsychological Tests | 2019 |
Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension.
Topics: Aged; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Method; Female; Humans; Kidney Diseases; Lithium; Long-Term Care; Longitudinal Studies; Male; Placebos; Single-Blind Method; Treatment Outcome | 2014 |
14 other study(ies) available for lithium and Cognitive Decline
| Article | Year |
|---|---|
Cognitive Impairment and Mossy Fiber Sprouting in a Rat Model of Drug-resistant Epilepsy Induced by Lithium-pilocarpine.
Topics: Animals; Cognitive Dysfunction; Epilepsy; Humans; Lithium; Mossy Fibers, Hippocampal; Pilocarpine; Rats | 2021 |
Klotho ameliorated cognitive deficits in a temporal lobe epilepsy rat model by inhibiting ferroptosis.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Convulsants; Epilepsy, Temporal Lobe; Ferroptosis; Genetic Therapy; Hippocampus; Iron Overload; Klotho Proteins; Lithium; Male; Neuroprotection; Pilocarpine; Rats; Rats, Sprague-Dawley | 2021 |
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Cognitive Dysfunction; Disease Models, Animal; Lamotrigine; Lithium; Mice; Valproic Acid | 2022 |
Electroconvulsive therapy plus lithium is associated with less cognitive impairment and drug-induced delirium in bipolar depression compared to unipolar depression.
Topics: Adult; Bipolar Disorder; Cognitive Dysfunction; Delirium; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Treatment Outcome | 2023 |
Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study.
Topics: Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Dizocilpine Maleate; Humans; Lithium; Mice; Pilot Projects; Quetiapine Fumarate; Task Performance and Analysis | 2023 |
Refinement of the Barnes and Morris water maze protocols improves characterization of spatial cognitive deficits in the lithium-pilocarpine rat model of epilepsy.
Topics: Animals; Cognition; Cognitive Dysfunction; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Lithium; Maze Learning; Morris Water Maze Test; Pilocarpine; Rats; Rats, Wistar; Spatial Learning | 2023 |
The Involvement of Canonical Wnt Signaling in Memory Impairment Induced by Chronic Cerebral Hypoperfusion in Mice.
Topics: Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Cognitive Dysfunction; Hippocampus; Lithium; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Wnt Signaling Pathway | 2020 |
Ameliorating Effects of Lithium on the Perinatal Ethanol-Induced Behavioral and Cognitive Dysfunction and Brain Oxidative Stress in Postnatal Developing Mice Pups.
Topics: Animals; Animals, Newborn; Behavior, Animal; Brain; Cognitive Dysfunction; Dose-Response Relationship, Drug; Ethanol; Female; Lithium; Male; Mice; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Protective Agents | 2020 |
Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain.
Topics: Animals; Anxiety; Cell Line, Tumor; Cell Proliferation; Cognitive Dysfunction; Cranial Irradiation; Disease Models, Animal; Hippocampus; Humans; Hyperkinesis; Lithium; Mice; Neurogenesis; Rats; Stem Cells | 2017 |
The role of necroptosis in status epilepticus-induced brain injury in juvenile rats.
Topics: Amygdala; Animals; Biomarkers; Brain Injuries; Cognitive Dysfunction; Lithium; Male; Necrosis; Neurons; Pilocarpine; Piriform Cortex; Random Allocation; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2017 |
Immunotherapy by targeting of VGKC complex for seizure control and prevention of cognitive impairment in a mouse model of epilepsy.
Topics: Animals; Antibodies; Cognitive Dysfunction; Disease Models, Animal; Humans; Immunotherapy; Lithium; Mice; Pilocarpine; Potassium Channels, Voltage-Gated; Seizures | 2018 |
Renal toxicity of long-term lithium treatment for mild cognitive impairment.
Topics: Antipsychotic Agents; Cognitive Dysfunction; Female; Humans; Kidney Diseases; Lithium; Male | 2015 |
Drs Aprahamian and Forlenza reply.
Topics: Antipsychotic Agents; Cognitive Dysfunction; Female; Humans; Kidney Diseases; Lithium; Male | 2015 |
Memantine attenuates cognitive impairments after status epilepticus induced in a lithium-pilocarpine model.
Topics: Animals; Cognition; Cognitive Dysfunction; Exploratory Behavior; Extinction, Psychological; Lithium; Male; Memantine; Orientation; Pilocarpine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Spatial Memory; Status Epilepticus; Treatment Outcome | 2016 |